Impaired Glucose Tolerance (IGT) Completed Phase 3 Trials for Rosiglitazone (DB00412)

Also known as: IGT - Impaired Glucose Tolerance / Intolerance to glucose / Impaired Glucose Tolerance (Prediabetes) / Glucose tolerance impaired / Impaired Glucose Tolerance / Glucose Intolerance / Decreased carbohydrate and glucose tolerance / Glucose tolerance decreased / Decreased glucose tolerance / Latent diabetes / Abnormal glucose NOS / Chemical diabetes

IndicationStatusPhase
DBCOND0042124 (Impaired Glucose Tolerance (IGT))Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01574820Role of Rosiglitazone on Pre-Diabetes Mellitus and Coronary Artery DiseaseTreatment
NCT00095654The DREAM (Diabetes Reduction Assessment With Ramipril and Rosiglitazone Medication) TrialPrevention
NCT00116922A Lifestyle and Combination Medication Therapy Diabetes Prevention StudyPrevention
NCT00140647The Study of Atherosclerosis With Ramipril and RosiglitazonePrevention
NCT00489229To Investigate the Effect of Rosiglitazone and Ramipril on Pre-clinical Vasculopathy in Diabetes and IGT PatientsTreatment